Dallas Nephrology Associates is pleased to welcome Dr. Tanya Geranpayeh, Nephrologist, to our team. Dr. Geranpayeh specializes in the management of patients with chronic kidney disease and other metabolic disorders.

Young lady with severe left flank pain with episodes of macro-microscopic hematuria with no proteinuria and normal eGFR.Kidney biopsy ? Nope. It is a ‘Nutcracker kidney’

First year fellow,Dr.Carolina Rodriguez,post call,showing her ‘ Cabo Rojo’ 🐰🇵🇷Boricua hasta en la Luna 👍

CONFIDENCE trial: In persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results and Research Summary:

This is your chance to start a fellowship with less financial stress. The ASN Loan Mitigation Program offers $50K over three years to help repay student loans. The deadline is approaching. Apply by Wednesday, August 20, at 2:00 p.m. EDT. 🔗 bit.ly/lmp2025

After more than 5 years and nearly 15,000 patients screened, main results from Tigris are out! Precision medicine isn’t for the faint of heart! PMX Hemoadsorption to remove endotoxin is highly effective in this very select population globenewswire.com/news-release/2…

Dallas Nephrology Associates extends a warm welcome to Dr. Amr W. Aljareh, Nephrologist, as he joins our respected team of providers. We are pleased to have Dr. Aljareh’s specialized knowledge in caring for patients with chronic kidney disease. Welcome Dr. Aljareh!

Core Curriculum by Biff F. Palmer and Deborah J. Clegg: Mixed Acid-Base Disturbances: Core Curriculum 2025 bit.ly/Palmer25CC (FREE)

Dallas Nephrology Associates is pleased to welcome Dr. Adam W. Tsen, Nephrologist, to our provider team. Dr. Tsen specializes in the management of patients with kidney disease and related metabolic disorders. Welcome Dr. Tsen!

‘CKF Cardio Kidney Failure’ 👌

Clinical Implementation of Urinary NGAL Testing for... : Kidney360 journals.lww.com/kidney360/abst…

2/ View the guideline and supplemental resources here: spr.ly/6016fUsGy

The 2025 High Blood Pressure Guideline has been released along with many accompanying articles. Check them all out today! Guideline: ahajrnls.org/4mhhrKg 2025 High Blood Pressure Guideline Journal Hub: ahajrnls.org/45l5Jsh

Can’t wait to dive into the new adult #Hypertension guidelines

A message from #ACGME President and CEO Debra F. Weinstein, MD recognizing #GMEProfessionalsDay. #MedEd

Very proud of Dr.Namitha Sudheer,our senior fellow representing #methodistdallas NBLU: Renal Leaders

RBC cast - brightfield, with SM stain - from patient with hydralazine-induced vasculitis #UrineMicroscopy #UrinarySediment

New in the The Lancet :Arguably the highest fibrosis improvement in #MASH trials to date #livertwitter Elliot Tapper Jörn Schattenberg Naim Alkhouri akerotx Scott Isaacs Nabil Noureddin Arun J. Sanyal Safety and efficacy of once-weekly efruxifermin versus placebo in metabolic

🩺 Protect your kidneys🫘 with ABCDE 🧩 A 🧪 Albuminuria B 💓 Blood pressure C 🩸 Cholesterol D 🍬 Diabetes E 🔬 eGFR Early checks = stronger 💙 & healthier kidneys! 🔗 doi.org/10.1093/ndt/gf… NDT #Kidney #CKD #Nephrology #MedTwitter

Chris King The Lancet Elliot Tapper Jörn Schattenberg Naim Alkhouri akerotx Scott Isaacs Nabil Noureddin Arun J. Sanyal It is an FGF-21. Bone health need to be assessed in MASLD patients including Vit D baseline levels and with FGF-21s and GLPs